NCT07398534

Brief Summary

The investigators compare negative pressure wound therapy (NPWT) using the PICO 7 system versus professional wound debridement alone in adult orthopedic patients with acute, non-infected wound dehiscence or diabetic foot ulcers. Patients are randomized 1:1 to either PICO therapy (minimum 7 days, up to 42 days) or standard wound care (professional debridement without NPWT). The primary outcome is wound closure without surgical revision at Day 42. The trial is stratified for diabetic foot ulcers to enable subgroup analysis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
26mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jan 2026Jun 2028

First Submitted

Initial submission to the registry

January 29, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

January 29, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 10, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

1.9 years

First QC Date

January 29, 2026

Last Update Submit

February 6, 2026

Conditions

Keywords

acute woundnegative pressure vacuum therapyprospective-randomized trial

Outcome Measures

Primary Outcomes (1)

  • Wound closure without surgical revision at Day 42

    Wound closure is defined as reduction of wound size by a minimum of 90% compared to baseline, without need for surgical revision. Wound failure is defined as persistent wound (less than 90% reduction) after 42 days or surgical wound revision during the study period.

    Day 42 (±7 days)

Secondary Outcomes (6)

  • 2. Rapidity of wound closure

    Day 7, 14, 21, 28, 35, and 42

  • Wound closure without surgical revision at Day 7, 14, 21, 28, and 35

    Day 7, 14, 21, 28, and 35 (±2 days)

  • 4. Wound closure for diabetic foot ulcers only (stratified analysis)

    Day 42 (±7 days)

  • 5. Adverse events related to wound therapy

    Day 1 to Day 42 (±7 days)

  • 6. Length of hospital stay

    Day 1 to Day 42 (±7 days)

  • +1 more secondary outcomes

Study Arms (2)

PICO

EXPERIMENTAL

Application of PICO 7 Single Use NPWT System at -80 mmHg for a minimum of 7 days. PICO therapy may be continued for up to 42 days based on clinical necessity. Device change every 7 days. Wound assessment weekly. SMITH \& NEPHEW MEDICAL LTD. PICO 7 15CM X 20CM; NEGATIVE PRESSURE WOUND THERAPY POWERED SUCTION PUMP (UDI 04582111156419). The PICO system creates a closed environment over the wound, evacuating exudate into an absorptive dressing while promoting wound closure through controlled suction.

Procedure: Professional Wound Care

Professional Wound CAre

OTHER

Professional wound debridement by specialized wound nurses, including dressing changes and local antiseptics if clinically indicated, without the use of any negative pressure device. Treatment for up to 42 days based on clinical necessity. Wound assessment weekly. Individualized professional wound care according to hospital and Swiss nursing guidelines. The intensity of debridement, dressing type, and antiseptic use lies at the discretion of the wound nurse and will be recorded.

Procedure: Professional Wound Care

Interventions

Professional wound debridement by specialized wound nurses, including dressing changes and local antiseptics if clinically indicated, without the use of any negative pressure device. Treatment for up to 42 days based on clinical necessity. Wound assessment weekly. Individualized professional wound care according to hospital and Swiss nursing guidelines. The intensity of debridement, dressing type, and antiseptic use lies at the discretion of the wound nurse and will be recorded.

PICOProfessional Wound CAre

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Age ≥ 18 years
  • Able to consent
  • Patient of orthopaedic surgery or of the (Diabetic) Foot Polyclinic at the Balgrist University Hospital
  • Presence of an acute, dehiscent, clinically uninfected wound requiring additional measures
  • First episode of wound treatment for the actual wound (no recurrences) in the last 12 months
  • Wound measuring ≥ 0.5 cm in wide, length or depth
  • days of scheduled follow-up
  • Bacterial orthopaedic infections of any nature, independently of implants or co-morbidities; according to clinical, laboratory, radiological, microbiological features of infection
  • First or second episode of infection

You may not qualify if:

  • \- Patient's individual refusal to participate
  • Patient already treated with any vacuum-assisted wound device for any wound in the last 12 months; independently of therapy success, the hospital or the localization of the prior wound
  • Underlying liquor leak (spine surgery)
  • Visually active bleeding from the wound
  • Wound size \>10 cm in any dimension
  • Anticipated active clinical follow-up of less than 42 days
  • Other wound treatments besides PICO and debridement (e.g. hyperbaric oxygen therapy, other negative-pressure devices, local antibiotics, local antibiotic dressings) (however, local antiseptics and dressing changes remain allowed)
  • Immediate surgical wound revision in the operating theatre for closure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balgrist University Hospital

Zurich, 8008, Switzerland

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Ilker Uçkay, Prof. Dr. med.

    Balgrist University Hospital, University of Zurich, Zurich, Swizerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Unblinded, prospective-randomized superiority trial in favor of PICO use
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. med. Ilker Uçkay

Study Record Dates

First Submitted

January 29, 2026

First Posted

February 10, 2026

Study Start

January 29, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

June 30, 2028

Last Updated

February 10, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

The investigators may share anonymized key elements upon reasonable scientific request to the corresponding persons

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
After the final analysis
Access Criteria
Reasonable scientific request to the corresponding Sponsor-Investigator
More information

Locations